ES469328A1 - Procedimiento para el enriquecimiento de una nueva glucopre-teina. - Google Patents

Procedimiento para el enriquecimiento de una nueva glucopre-teina.

Info

Publication number
ES469328A1
ES469328A1 ES469328A ES469328A ES469328A1 ES 469328 A1 ES469328 A1 ES 469328A1 ES 469328 A ES469328 A ES 469328A ES 469328 A ES469328 A ES 469328A ES 469328 A1 ES469328 A1 ES 469328A1
Authority
ES
Spain
Prior art keywords
glycoprotein
alpha
protein
isolating
acetylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469328A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES469328A1 publication Critical patent/ES469328A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid
ES469328A 1977-05-07 1978-05-02 Procedimiento para el enriquecimiento de una nueva glucopre-teina. Expired ES469328A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2720704A DE2720704C2 (de) 1977-05-07 1977-05-07 Neues Glycoprotein, Verfahren zu seiner Herstellung und seine Verwendung

Publications (1)

Publication Number Publication Date
ES469328A1 true ES469328A1 (es) 1978-11-16

Family

ID=6008386

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469328A Expired ES469328A1 (es) 1977-05-07 1978-05-02 Procedimiento para el enriquecimiento de una nueva glucopre-teina.

Country Status (19)

Country Link
US (1) US4217339A (es)
JP (1) JPS53139712A (es)
AT (1) AT365454B (es)
AU (1) AU517457B2 (es)
BE (1) BE866807A (es)
CA (1) CA1107648A (es)
CH (1) CH634334A5 (es)
DE (1) DE2720704C2 (es)
DK (1) DK198178A (es)
ES (1) ES469328A1 (es)
FR (1) FR2389637B1 (es)
GB (1) GB1600305A (es)
IE (1) IE46754B1 (es)
IT (1) IT1111178B (es)
LU (1) LU79607A1 (es)
NL (1) NL7804885A (es)
NZ (1) NZ187185A (es)
SE (1) SE7805132L (es)
ZA (1) ZA782583B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718325C2 (de) * 1977-04-25 1986-09-25 Behringwerke Ag, 3550 Marburg Leucinreiches 3,1-S-α↓2↓-Glykoprotein sowie dessen Verwendung
DE2745680A1 (de) * 1977-10-11 1979-04-12 Behringwerke Ag Kontrazeptives mittel
DE2842467A1 (de) * 1978-09-29 1980-04-10 Behringwerke Ag Neues ubiquitaeres gewebsprotein pp tief 8
DE2854759A1 (de) * 1978-12-19 1980-07-10 Behringwerke Ag Neues plazentaspezifisches gewebsprotein pp tief 10
DE2946458A1 (de) * 1979-11-17 1981-06-11 Behringwerke Ag, 3550 Marburg Neues protein pp(pfeil abwaerts)11(pfeil abwaerts)
DE2952792A1 (de) * 1979-12-31 1981-07-02 Behringwerke Ag, 3550 Marburg Neues protein (pp(pfeil abwaerts)15(pfeil abwaerts)) mit immunsuppressiver wirkung
DE3013724A1 (de) * 1980-04-10 1981-10-15 Behringwerke Ag, 3550 Marburg Neues protein pp (pfeil abwaerts)9(pfeil abwaerts), verfahren zu seiner anreicherung und gewinnung sowieseine verwendung
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
DE3109629A1 (de) * 1981-03-13 1982-09-23 Behringwerke Ag, 3550 Marburg "neues protein (pp(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung"
US4423036A (en) * 1981-08-03 1983-12-27 Research Corporation Acid soluble platelet aggregating material isolated from human umbilical cord
DE3315000A1 (de) * 1983-04-26 1984-10-31 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)4(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
US4554256A (en) * 1983-07-21 1985-11-19 The Idaho Research Foundation, Inc. Antigen associated with early detection of mammalian pregnancy
DE3410694A1 (de) * 1984-03-23 1985-10-03 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)2(pfeil abwaerts)(pfeil abwaerts)1(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
JPS60199819A (ja) * 1984-03-23 1985-10-09 Kowa Co トロンビン結合性物質およびその製法
US4895804A (en) * 1984-07-06 1990-01-23 University Of Minnesota Bovine antigen glycoprotein, related antibody, and use in detection of pregnancy in cattle
US4755460A (en) * 1984-07-06 1988-07-05 The Regents Of The Univ. Of Minnesota Bovine antigen glycoprotein, related antibody, and use in detection of pregnancy in cattle
JPS61294366A (ja) * 1985-06-24 1986-12-25 Toubishi Yakuhin Kogyo Kk 糖鎖に特異的な抗体の検出用試薬及びその使用
CA1265446A (en) * 1985-09-30 1990-02-06 Masahiro Maki Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component
JPH0689014B2 (ja) * 1986-01-21 1994-11-09 興和株式会社 トロンビン結合性物質およびその製法
ATE113062T1 (de) * 1986-07-15 1994-11-15 Kowa Co Throminbindende substanz und verfahren zu ihrer herstellung.
DE3639561A1 (de) * 1986-11-20 1988-06-01 Baumann Hanno Verfahren zur herstellung von nicht-thrombogenen substraten
US4937324A (en) * 1987-02-06 1990-06-26 Zymogenetics, Inc. Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity
JPH0266456A (ja) * 1988-08-31 1990-03-06 Saikin Kagaku Kenkyusho:Kk 疾病動物の一次診断方法、それに使用する診断試薬及びその製造方法
KR950014915B1 (ko) * 1991-06-19 1995-12-18 주식회사녹십자 탈시알로당단백-포함화합물
US20030220233A1 (en) * 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
AU7398996A (en) * 1995-10-11 1997-04-30 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US6449562B1 (en) 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US8148171B2 (en) 2001-10-09 2012-04-03 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US20050164261A1 (en) * 2001-10-09 2005-07-28 Chandler Don J. Multiplexed analysis of clinical specimens apparatus and methods
BG65084B1 (bg) * 2002-03-13 2007-02-28 Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" Нов клас биоактивни гликопротеини

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2221261A1 (de) * 1972-04-29 1973-11-15 Behringwerke Ag Ap-glykoproteine und verfahren zu ihrer isolierung
AR207237A1 (es) * 1974-02-25 1976-09-22 Thomas A Procedimiento para obtener extractos biologicos estables liofilizados solubles constituidos por complejos proteicos termorresistentes
DE2612479A1 (de) * 1975-04-18 1976-10-21 Behringwerke Ag Verfahren zur anreicherung des schwangerschaftsspezifischen beta tief 1- glycoproteins
DE2616984C3 (de) * 1976-04-17 1981-10-29 Behringwerke Ag, 3550 Marburg Verfahren zur Isolierung und Reinigung eines plazentenspezifischen Glycoproteins
DE2640387C3 (de) * 1976-09-08 1981-01-22 Behringwerke Ag, 3550 Marburg Gewebespezifisches Protein und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
DE2720704C2 (de) 1986-09-25
ATA327278A (de) 1981-06-15
DK198178A (da) 1978-11-08
AT365454B (de) 1982-01-25
GB1600305A (en) 1981-10-14
LU79607A1 (de) 1979-02-02
IE46754B1 (en) 1983-09-07
ZA782583B (en) 1979-04-25
DE2720704A1 (de) 1978-11-16
JPS53139712A (en) 1978-12-06
AU517457B2 (en) 1981-07-30
CH634334A5 (de) 1983-01-31
IE780912L (en) 1978-11-07
AU3581678A (en) 1979-11-08
BE866807A (fr) 1978-11-08
FR2389637B1 (es) 1982-08-27
CA1107648A (en) 1981-08-25
JPS6361318B2 (es) 1988-11-28
US4217339A (en) 1980-08-12
FR2389637A1 (es) 1978-12-01
SE7805132L (sv) 1978-11-08
NL7804885A (nl) 1978-11-09
IT1111178B (it) 1986-01-13
IT7823101A0 (it) 1978-05-05
NZ187185A (en) 1981-05-15

Similar Documents

Publication Publication Date Title
ES469328A1 (es) Procedimiento para el enriquecimiento de una nueva glucopre-teina.
ES8603271A1 (es) Un metodo de producir una composicion de interleuquina-2
IE781198L (en) Glycoprotein isolation
EP0060491A3 (en) Protein pp16, process for concentrating and isolating it, and its use
Boros et al. Induction of granulomatous and elicitation of cutaneous sensitivity by partially purified SEA of Schistosoma mansoni
Novogrodsky Selective activation of mouse T and B lymphocytes by periodate, galactose oxidase and soybean agglutinin
AU555759B2 (en) Protein (pp-17) derived from human placenta
GR860329B (en) Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof
Geller et al. Electrophoresis of saliva
ES468932A1 (es) Procedimiento para la preparacion de una proteina.
IE780801L (en) Leucine-rich 3,1-5-ó(2) -glycoprotein and process for its¹isolation¹¹isolation
Saxena et al. Purification and characterisation of an immunosuppressive factor from normal human seminal plasma
Diel et al. Histamine secretion in leukocyte incubates of patients with allergic hyperreactivity induced by somatostatin-14 and somatostatin-28
Hamazaki et al. Enzymatic Hydrolysis of Disaccharide Unit of Collagen: Isolation of 2‐O‐α‐d‐Glucopyranosyl‐O‐β‐d‐galactopyranosyl‐hydroxylysine Glucohydrolase from Rat Spleens
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
Kondo CELL‐BINDING SUBSTANCES IN SEA URCHIN EMBRYOS
AU1948788A (en) Expression of immunologically active proteins of human b-lymphotropic virus
IE873143L (en) HOMOGENEOUS SHEEP TllTS AS AN INTERMEDIATE FOR THE¹PREPARATION OF HUMAN Tllts, AND THE USE THEREOF
MacDonald et al. Isolation and partial characterization of an antibody enhancing factor from leukaemic owl monkey cell cultures.
Keller Some factors affecting the cytotoxic immune reaction of rat mast cells
Deane et al. Characterisation of a putative MLR antigen
JPS6475423A (en) Dramatic drug for external use
IT8349398A0 (it) Pepsina immobilizzata per l'impiego nella eliminazione di immunocomplessi dal sangue e procedimento per eliminare immunocomplessi dal sangue impiegando la pepsina immobilizzata
EP0070167A3 (en) Hypertension treatment
Hansen et al. Large scale preparation of liver growth factor for cultivation of nematodes